The expression of transforming growth factor-beta s and TGF-beta receptor mRNA and protein and the effect of TGF-beta s on human myometrial smooth muscle cells in vitro

被引:53
|
作者
Tang, XM [1 ]
Dou, QC [1 ]
Zhao, Y [1 ]
McLean, F [1 ]
Davis, J [1 ]
Chegini, N [1 ]
机构
[1] UNIV FLORIDA,COLL MED,DEPT OBSTET & GYNECOL,GAINESVILLE,FL 32610
关键词
expression; human; myometrium; TGF-beta; TGF-beta receptors;
D O I
10.1093/molehr/3.3.233
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
In this study we investigated the expression of transforming growth factor-beta (TGF-beta) isoform and TGF-beta receptor mRNA and protein, and the effect of TGF-beta 1-3 on the rate of DNA synthesis and proliferation of human myometrial smooth muscle cells in vitro. To determine these, we utilized primary cultures of myometrial smooth muscle cells, standard and competitive quantitative reverse transcription-polymerase chain reaction (RT-PCR), immunocytochemistry enzyme-linked immunoassay, radioreceptor assay, [H-3] thymidine incorporation and cell proliferation assay. Standard RT-PCR and immunocytochemistry revealed that myometrial smooth muscle cells express TGF beta 1-3 and TGF-beta type I-III receptor (TGF-beta R) mRNA and protein. Quantitative RT-PCR, using an external synthetic RNA standard, indicated that the cells express 10 copies/cell of TGF-beta 1 and TGF-beta 2, less than one copy/cell of TGF-beta 3 and TGF-P type IR, three copies/cell of type IIIR, and >200 copies/cell of TGF-beta type IIR mRNA. The cells also synthesized and released TGF-beta 1 at the rate of 7.8 +/- 0.7 ng/10(6) cells, of which 1.4 +/- 0.2 ng/10(6) cells was in an active form. The rate of [3H] thymidine incorporation or proliferation of subconfluent quiescent smooth muscle cells was not altered by TGF-beta s (0.1-10 ng/ml) under serum-free conditions, nor in the presence of 10% fetal bovine serum (FBS). TGF-beta 1-3 at 0.25-0.5 ng/ml in the presence of 2% FBS, which induces half maximal stimulation of these cells, stimulated the rate (P < 0.05), whereas at higher doses it reduced the rate of [H-3]-thymidine incorporation compared to the controls. The effect of TGF-beta was partially reversible using neutralizing antibodies specific to TGF-beta 1, TGF-beta 2 (10 mu g/ml) or TGF-beta 3 (3-6 mu g/ml). TGF-beta s had no significant effect on cell proliferation determined by cell counting. The data indicate that human myometrial smooth muscle cells express the necessary components of the TGF-beta system, suggesting an autocrine/paracrine role for TGF-beta s in myometrium.
引用
收藏
页码:233 / 240
页数:8
相关论文
共 50 条
  • [41] TRANSFORMING GROWTH-FACTOR-BETA (TGF-BETA) IN HUMAN-MILK
    SAITO, S
    YOSHIDA, M
    ICHIJO, M
    ISHIZAKA, S
    TSUJII, T
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 1993, 94 (01): : 220 - 224
  • [42] Transforming growth factor beta (TGF-beta) in human and rat amniotic fluid
    McGettigan, MC
    Breeden, LM
    Larson, JE
    PEDIATRIC RESEARCH, 1996, 39 (04) : 2024 - 2024
  • [43] Genetic change in transforming growth factor beta (TGF-beta) receptor type I gene correlates with insensitivity to TGF-beta 1 in human prostate cancer cells
    Kim, IY
    Ahn, HJ
    Zelner, DJ
    Shaw, JW
    Sensibar, JA
    Kim, JH
    Kato, M
    Lee, C
    CANCER RESEARCH, 1996, 56 (01) : 44 - 48
  • [44] Gelatinase A, transforming growth factor-beta 1 (TGF-beta 1) and retinoids in fibrotic human livers
    Gimenez, A
    Deulofeu, R
    Roman, J
    Enrich, C
    Caballeria, J
    Rodes, J
    MOLECULAR BIOLOGY OF THE CELL, 1996, 7 : 1380 - 1380
  • [45] Differential protein expression analysis of transforming growth factor-beta (TGF-beta) signaling and the impact of a specific low-molecular-weight TGF-beta inhibitor in human malignant glioma cell lines
    Alzate, O
    Osorio, C
    Herbstreith, M
    Hjelmeland, M
    Buechler, R
    Ehlers, M
    Rich, J
    NEURO-ONCOLOGY, 2005, 7 (03) : 366 - 366
  • [46] EXTRACELLULAR DOMAIN OF TRANSFORMING GROWTH-FACTOR-BETA (TGF-BETA) RECEPTOR TYPE-II ENCODES A SOLUBLE TGF-BETA BINDING-PROTEIN
    SEGARINI, P
    OLSEN, D
    MASCARENHAS, D
    CARRILLO, P
    SCHMIDT, DK
    MORITZ, MS
    DASCH, J
    JOURNAL OF CELLULAR BIOCHEMISTRY, 1993, : 138 - 138
  • [47] Expression of TGF-beta isoforms and their receptor mRNA's in cultured human lamina cribrosa cells
    Lambert, W
    Agarwal, R
    Clark, AF
    Wordinger, RJ
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 1997, 38 (04) : 801 - 801
  • [48] HEPATIC HANDLING OF TRANSFORMING GROWTH-FACTOR-BETA (TGF-BETA)
    KOST, LJ
    COFFEY, RJ
    MOSES, HL
    LARUSSO, NF
    JOURNAL OF CELL BIOLOGY, 1986, 103 (05): : A446 - A446
  • [49] TRANSFORMING GROWTH-FACTOR-BETA (TGF-BETA) AND ARTICULAR CHONDROCYTES
    PUJOL, JP
    GALERA, P
    PRONOST, S
    BOUMEDIENE, K
    VIVIEN, D
    MACRO, M
    MIN, W
    REDINI, F
    PENFORNIS, H
    DAIREAUX, M
    BOITTIN, M
    STAEDEL, C
    BOGDANOWICZ, P
    ANNALES D ENDOCRINOLOGIE, 1994, 55 (02) : 109 - 120
  • [50] Release of transforming growth factor-beta (TGF-beta) and fibronectin by alveolar macrophages in airway diseases
    Vignola, AM
    Chanez, P
    Chiappara, G
    Merendino, A
    Zinnanti, E
    Bousquet, J
    Bellia, V
    Bonsignore, G
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 1996, 106 (01): : 114 - 119